"instanceType","uuid:ID","name","text","id","description","label"
"Objective","f45b7001-73ad-47dc-8961-fa9e049b3218","OBJ1","To determine if there is a statistically significant relationship (overall Type 1 erroralpha=0.05) between the change in both the ADAS-Cog (11) and CIBIC+ scores, and drug dose (0, 50 cm2 [54 mg], and 75 cm2 [81 mg]).","Objective_1","Main objective",""
"Objective","0a7c973b-df71-45a3-8643-c95174a58955","OBJ2","To document the safety profile of the xanomeline TTS.","Objective_2","Safety",""
"Objective","4905fee3-fa6b-4f5e-92df-3d75be771714","OBJ3","To assess the dose-dependent improvement in behavior. Improved scores on the Revised Neuropsychiatric Inventory (NPI-X) will indicate improvement in these
areas.","Objective_3","Behaviour",""
